-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Oral and Poster Abstracts

Saturday, December 3, 2016

7:30 AM-9:00 AM

Hemoglobinopathies, Excluding Thalassemia—Clinical

Blood Coagulation and Fibrinolytic Factors

Basic Science and Clinical Practice in Blood Transfusion

Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells

Molecular Pharmacology and Drug Resistance in Myeloid Diseases

Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis

Lymphoma: Pre-Clinical—Chemotherapy and Biologic Agents

Myelodysplastic Syndromes—Clinical Studies

CLL: Therapy, excluding Transplantation

Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities

Clinical Allogeneic Transplantation: Results

9:30 AM-11:00 AM

Regulation of Iron Metabolism

Blood Coagulation and Fibrinolytic Factors

Antithrombotic Therapy

Basic Science and Clinical Practice in Blood Transfusion

Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation

Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Retrospective/Observational Studies

Myelodysplastic Syndromes—Clinical Studies

Myeloma: Biology and Pathophysiology, excluding Therapy

12:00 PM-1:30 PM

Hemoglobinopathies, Excluding Thalassemia—Clinical

Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections

Disorders of Platelet Number or Function

Antithrombotic Therapy

Mantle Cell, Follicular, and Other Indolent B-Cell Lymphoma—Clinical Studies

Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Retrospective/Observational Studies

2:00 PM-3:30 PM

Hemoglobinopathies, Excluding Thalassemia—Basic and Translational Science

Disorders of Platelet Number or Function

Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells

Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation

Hodgkin Lymphoma and T/NK Cell Lymphoma—Clinical Studies

CLL: Biology and Pathophysiology, excluding Therapy

Myeloma: Biology and Pathophysiology, excluding Therapy

4:00 PM-5:30 PM

Regulation of Iron Metabolism

Blood Coagulation and Fibrinolytic Factors

Disorders of Coagulation or Fibrinolysis

Acute Myeloid Leukemia: Clinical Studies

Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation

Myelodysplastic Syndromes—Clinical Studies

CLL: Therapy, excluding Transplantation

Myeloma: Biology and Pathophysiology, excluding Therapy

Myeloma: Therapy, excluding Transplantation

Outcomes Research—Non-Malignant Conditions

5:30 PM-7:30 PM

Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron

Regulation of Iron Metabolism

Thalassemia and Globin Gene Regulation

Hemoglobinopathies, Excluding Thalassemia—Basic and Translational Science

Hemoglobinopathies, Excluding Thalassemia—Clinical

Granulocytes, Monocytes, and Macrophages

Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections

Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry

Disorders of Platelet Number or Function

Blood Coagulation and Fibrinolytic Factors

Disorders of Coagulation or Fibrinolysis

Pathophysiology of Thrombosis

Antithrombotic Therapy

Basic Science and Clinical Practice in Blood Transfusion

Hematopoietic Stem and Progenitor Biology

Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation

Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells

Bone Marrow Failure

Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation

Oncogenes and Tumor Suppressors

Molecular Pharmacology and Drug Resistance in Myeloid Diseases

Molecular Pharmacology, Drug Resistance—Lymphoid and Other Diseases

Acute Lymphoblastic Leukemia: Clinical Studies

Acute Myeloid Leukemia: Clinical Studies

Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation

Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation

Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation

Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis

Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis

Lymphoma—Genetic/Epigenetic Biology

Lymphoma Biology—Non-Genetic Studies

Mantle Cell, Follicular, and Other Indolent B-Cell Lymphoma—Clinical Studies

Hodgkin Lymphoma and T/NK Cell Lymphoma—Clinical Studies

Lymphoma: Pre-Clinical—Chemotherapy and Biologic Agents

Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Prospective Clinical Trials

Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Retrospective/Observational Studies

Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy

Chronic Myeloid Leukemia: Therapy

Myeloproliferative Syndromes: Clinical

Myeloproliferative Syndromes: Basic Science

Myelodysplastic Syndromes—Basic and Translational Studies

Myelodysplastic Syndromes—Clinical Studies

CLL: Biology and Pathophysiology, excluding Therapy

CLL: Therapy, excluding Transplantation

Myeloma: Biology and Pathophysiology, excluding Therapy

Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy

Myeloma: Therapy, excluding Transplantation

Experimental Transplantation: Basic Biology, Pre-Clinical Models

Adoptive Immunotherapy

Cell Collection and Processing

Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities

Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution

Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence

Clinical Autologous Transplantation: Results

Clinical Allogeneic Transplantation: Results

Gene Therapy and Transfer

Chemical Biology and Experimental Therapeutics

Health Services Research—Non-Malignant Conditions

Health Services Research—Malignant Conditions

Outcomes Research—Non-Malignant Conditions

Outcomes Research—Malignant Conditions

Sunday, December 4, 2016

7:30 AM-9:00 AM

Hemoglobinopathies, Excluding Thalassemia—Basic and Translational Science

Pathophysiology of Thrombosis

Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation

Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis

Lymphoma: Pre-Clinical—Chemotherapy and Biologic Agents

Myelodysplastic Syndromes—Clinical Studies

CLL: Biology and Pathophysiology, excluding Therapy

Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy

Health Services Research—Non-Malignant Conditions

7:30 AM-9:15 AM

Regulation of Iron Metabolism

9:30 AM-11:00 AM

Thalassemia and Globin Gene Regulation

Disorders of Coagulation or Fibrinolysis

Bone Marrow Failure

Acute Myeloid Leukemia: Clinical Studies

Myelodysplastic Syndromes—Clinical Studies

CLL: Biology and Pathophysiology, excluding Therapy

Myeloma: Biology and Pathophysiology, excluding Therapy

12:00 PM-1:30 PM

Disorders of Platelet Number or Function

Hematopoietic Stem and Progenitor Biology

Myeloma: Biology and Pathophysiology, excluding Therapy

Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy

Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution

Outcomes Research—Malignant Conditions

4:30 PM-6:00 PM

Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron

Granulocytes, Monocytes, and Macrophages

Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry

Pathophysiology of Thrombosis

Hematopoietic Stem and Progenitor Biology

Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells

Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation

Oncogenes and Tumor Suppressors

Acute Myeloid Leukemia: Clinical Studies

Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis

Lymphoma—Genetic/Epigenetic Biology

Lymphoma: Pre-Clinical—Chemotherapy and Biologic Agents

Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Prospective Clinical Trials

Myeloproliferative Syndromes: Clinical

Myeloma: Biology and Pathophysiology, excluding Therapy

Myeloma: Therapy, excluding Transplantation

Experimental Transplantation: Basic Biology, Pre-Clinical Models

Adoptive Immunotherapy

Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution

Clinical Autologous Transplantation: Results

Clinical Allogeneic Transplantation: Results

Chemical Biology and Experimental Therapeutics

Outcomes Research—Non-Malignant Conditions

Outcomes Research—Malignant Conditions

6:00 PM-8:00 PM

Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron

Regulation of Iron Metabolism

Thalassemia and Globin Gene Regulation

Hemoglobinopathies, Excluding Thalassemia—Basic and Translational Science

Hemoglobinopathies, Excluding Thalassemia—Clinical

Granulocytes, Monocytes, and Macrophages

Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections

Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry

Disorders of Platelet Number or Function

Blood Coagulation and Fibrinolytic Factors

Disorders of Coagulation or Fibrinolysis

Pathophysiology of Thrombosis

Antithrombotic Therapy

Basic Science and Clinical Practice in Blood Transfusion

Hematopoietic Stem and Progenitor Biology

Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation

Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells

Bone Marrow Failure

Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation

Oncogenes and Tumor Suppressors

Molecular Pharmacology and Drug Resistance in Myeloid Diseases

Molecular Pharmacology, Drug Resistance—Lymphoid and Other Diseases

Acute Lymphoblastic Leukemia: Clinical Studies

Acute Myeloid Leukemia: Clinical Studies

Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation

Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation

Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation

Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis

Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis

Lymphoma—Genetic/Epigenetic Biology

Lymphoma Biology—Non-Genetic Studies

Mantle Cell, Follicular, and Other Indolent B-Cell Lymphoma—Clinical Studies

Hodgkin Lymphoma and T/NK Cell Lymphoma—Clinical Studies

Lymphoma: Pre-Clinical—Chemotherapy and Biologic Agents

Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Prospective Clinical Trials

Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Retrospective/Observational Studies

Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy

Chronic Myeloid Leukemia: Therapy

Myeloproliferative Syndromes: Clinical

Myeloproliferative Syndromes: Basic Science

Myelodysplastic Syndromes—Basic and Translational Studies

Myelodysplastic Syndromes—Clinical Studies

CLL: Biology and Pathophysiology, excluding Therapy

CLL: Therapy, excluding Transplantation

Myeloma: Biology and Pathophysiology, excluding Therapy

Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy

Myeloma: Therapy, excluding Transplantation

Experimental Transplantation: Basic Biology, Pre-Clinical Models

Adoptive Immunotherapy

Cell Collection and Processing

Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities

Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution

Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence

Clinical Autologous Transplantation: Results

Clinical Allogeneic Transplantation: Results

Gene Therapy and Transfer

Chemical Biology and Experimental Therapeutics

Health Services Research—Non-Malignant Conditions

Health Services Research—Malignant Conditions

Outcomes Research—Non-Malignant Conditions

Outcomes Research—Malignant Conditions

Monday, December 5, 2016

7:00 AM-8:30 AM

Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron

Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections

Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry

Disorders of Coagulation or Fibrinolysis

Hematopoietic Stem and Progenitor Biology

Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation

Molecular Pharmacology and Drug Resistance in Myeloid Diseases

Acute Lymphoblastic Leukemia: Clinical Studies

Acute Myeloid Leukemia: Clinical Studies

Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis

Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis

Lymphoma—Genetic/Epigenetic Biology

Mantle Cell, Follicular, and Other Indolent B-Cell Lymphoma—Clinical Studies

Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Prospective Clinical Trials

Chronic Myeloid Leukemia: Therapy

Myeloproliferative Syndromes: Basic Science

CLL: Therapy, excluding Transplantation

Myeloma: Therapy, excluding Transplantation

Adoptive Immunotherapy

Cell Collection and Processing

Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution

Clinical Autologous Transplantation: Results

Clinical Allogeneic Transplantation: Results

Health Services Research—Malignant Conditions

Outcomes Research—Malignant Conditions

7:00 AM-8:45 AM

Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities

10:30 AM-12:00 PM

Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron

Granulocytes, Monocytes, and Macrophages

Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry

Pathophysiology of Thrombosis

Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation

Bone Marrow Failure

Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation

Oncogenes and Tumor Suppressors

Molecular Pharmacology and Drug Resistance in Myeloid Diseases

Molecular Pharmacology, Drug Resistance—Lymphoid and Other Diseases

Acute Lymphoblastic Leukemia: Clinical Studies

Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation

Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis

Lymphoma Biology—Non-Genetic Studies

Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Prospective Clinical Trials

Chronic Myeloid Leukemia: Therapy

Myeloproliferative Syndromes: Basic Science

Myeloma: Biology and Pathophysiology, excluding Therapy

Experimental Transplantation: Basic Biology, Pre-Clinical Models

Adoptive Immunotherapy

Cell Collection and Processing

Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence

Clinical Allogeneic Transplantation: Results

Chemical Biology and Experimental Therapeutics

Health Services Research—Malignant Conditions

2:45 PM-4:15 PM

Thalassemia and Globin Gene Regulation

Hemoglobinopathies, Excluding Thalassemia—Basic and Translational Science

Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections

Disorders of Platelet Number or Function

Disorders of Coagulation or Fibrinolysis

Antithrombotic Therapy

Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation

Molecular Pharmacology, Drug Resistance—Lymphoid and Other Diseases

Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation

Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation

Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis

Lymphoma Biology—Non-Genetic Studies

Hodgkin Lymphoma and T/NK Cell Lymphoma—Clinical Studies

Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Retrospective/Observational Studies

Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy

Chronic Myeloid Leukemia: Therapy

Myeloproliferative Syndromes: Clinical

Myeloproliferative Syndromes: Basic Science

Myelodysplastic Syndromes—Basic and Translational Studies

Myelodysplastic Syndromes—Basic and Translational Studies

CLL: Biology and Pathophysiology, excluding Therapy

Myeloma: Therapy, excluding Transplantation

Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities

Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence

Clinical Autologous Transplantation: Results

Gene Therapy and Transfer

Health Services Research—Non-Malignant Conditions

4:30 PM-6:00 PM

Thalassemia and Globin Gene Regulation

Hemoglobinopathies, Excluding Thalassemia—Clinical

Granulocytes, Monocytes, and Macrophages

Basic Science and Clinical Practice in Blood Transfusion

Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation

Bone Marrow Failure

Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation

Oncogenes and Tumor Suppressors

Molecular Pharmacology, Drug Resistance—Lymphoid and Other Diseases

Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation

Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation

Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis

Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis

Lymphoma—Genetic/Epigenetic Biology

Lymphoma Biology—Non-Genetic Studies

Mantle Cell, Follicular, and Other Indolent B-Cell Lymphoma—Clinical Studies

Hodgkin Lymphoma and T/NK Cell Lymphoma—Clinical Studies

Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Retrospective/Observational Studies

Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy

Myeloproliferative Syndromes: Clinical

Myelodysplastic Syndromes—Basic and Translational Studies

Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy

Myeloma: Therapy, excluding Transplantation

Myeloma: Therapy, excluding Transplantation

Experimental Transplantation: Basic Biology, Pre-Clinical Models

Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence

Clinical Allogeneic Transplantation: Results

Gene Therapy and Transfer

Health Services Research—Non-Malignant Conditions

Health Services Research—Malignant Conditions

Outcomes Research—Malignant Conditions

6:00 PM-8:00 PM

Regulation of Iron Metabolism

Thalassemia and Globin Gene Regulation

Hemoglobinopathies, Excluding Thalassemia—Basic and Translational Science

Hemoglobinopathies, Excluding Thalassemia—Clinical

Granulocytes, Monocytes, and Macrophages

Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections

Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry

Disorders of Platelet Number or Function

Blood Coagulation and Fibrinolytic Factors

Disorders of Coagulation or Fibrinolysis

Pathophysiology of Thrombosis

Antithrombotic Therapy

Basic Science and Clinical Practice in Blood Transfusion

Hematopoietic Stem and Progenitor Biology

Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation

Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells

Bone Marrow Failure

Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation

Molecular Pharmacology and Drug Resistance in Myeloid Diseases

Molecular Pharmacology, Drug Resistance—Lymphoid and Other Diseases

Acute Lymphoblastic Leukemia: Clinical Studies

Acute Myeloid Leukemia: Clinical Studies

Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation

Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation

Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation

Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis

Lymphoma—Genetic/Epigenetic Biology

Lymphoma Biology—Non-Genetic Studies

Hodgkin Lymphoma and T/NK Cell Lymphoma—Clinical Studies

Lymphoma: Pre-Clinical—Chemotherapy and Biologic Agents

Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Prospective Clinical Trials

Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Retrospective/Observational Studies

Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy

Myeloproliferative Syndromes: Clinical

Myeloproliferative Syndromes: Basic Science

Myelodysplastic Syndromes—Basic and Translational Studies

Myelodysplastic Syndromes—Clinical Studies

CLL: Biology and Pathophysiology, excluding Therapy

CLL: Therapy, excluding Transplantation

Myeloma: Biology and Pathophysiology, excluding Therapy

Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy

Myeloma: Therapy, excluding Transplantation

Experimental Transplantation: Basic Biology, Pre-Clinical Models

Adoptive Immunotherapy

Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution

Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence

Clinical Autologous Transplantation: Results

Clinical Allogeneic Transplantation: Results

Gene Therapy and Transfer

Chemical Biology and Experimental Therapeutics

Health Services Research—Non-Malignant Conditions

Outcomes Research—Non-Malignant Conditions

Outcomes Research—Malignant Conditions

6:15 PM-7:45 PM

Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron

Oncogenes and Tumor Suppressors

Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis

Mantle Cell, Follicular, and Other Indolent B-Cell Lymphoma—Clinical Studies

Chronic Myeloid Leukemia: Therapy

Cell Collection and Processing

Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities

Health Services Research—Malignant Conditions